Chapter 9

### ACETYLCHOLINE AND ITS MUSCARINIC RECEPTOR TARGET

Muscarinic acetylcholine receptors in the peripheral nervous system occur primarily on autonomic effector cells innervated by postganglionic parasympathetic nerves. Muscarinic receptors are also present in autonomic ganglia and on some cells (e.g., vascular endothelial cells) that, paradoxically, receive little or no cholinergic innervation. Within the central nervous system (CNS), the hippocampus, cortex, and thalamus have high densities of muscarinic receptors.

Acetylcholine (ACh), the naturally occurring neurotransmitter for these receptors, has virtually no systemic therapeutic applications because its actions are diffuse, and its hydrolysis, catalyzed by both acetylcholinesterase (AChE) and plasma butyrylcholinesterase, is rapid. Muscarinic agonists mimic the effects of ACh at these sites. These agonists typically are longer-acting congeners of ACh or natural alkaloids, some of which stimulate nicotinic as well as muscarinic receptors.

The mechanisms of action of endogenous ACh at the postjunctional membranes of the effector cells and neurons that represent different types of cholinergic synapses are discussed in Chapter 8. To recapitulate, these synapses are found at: 1) autonomic effector sites innervated by postganglionic parasympathetic nerves (or, in the sweat glands, by postganglionic sympathetic nerves); 2) sympathetic and parasympathetic ganglia and the adrenal medulla, innervated by preganglionic autonomic nerves; 3) motor end plates on skeletal muscle, innervated by somatic motor nerves; and 4) certain synapses in the CNS (Krnjevic, 2004), where ACh can have either pre- or postsynaptic actions. When ACh is administered systemically, it can potentially act at all of these sites; however, as a quaternary ammonium compound, its penetration to the CNS is limited, and the amount of ACh that reaches peripheral areas with low blood flow is limited due to hydrolysis by plasma butyrylcholinesterase.

The actions of ACh and related drugs at autonomic effector sites are referred to as muscarinic, based on the observation that the alkaloid muscarine acts selectively at those sites and produces the same qualitative effects as ACh. The muscarinic, or parasympathomimetic, actions of the drugs considered in this chapter are practically equivalent to the parasympathetic effects of ACh listed in Table 8–1. Muscarinic receptors are present in autonomic ganglia and the adrenal medulla but primarily function to modulate the nicotinic actions of ACh at these sites (Chapter 11). In the CNS, muscarinic receptors are widely distributed and have a role in mediating many important responses. The differences between the actions of ACh and other muscarinic agonists are largely quantitative, with limited selectivity for one organ system or another. All of the actions of ACh and its congeners at muscarinic receptors can be blocked by atropine.

#### Properties and Subtypes of Muscarinic Receptors

Muscarinic receptors were characterized initially by analysis of the responses of cells and organ systems in the periphery and the CNS. For example, differential effects of two muscarinic agonists, bethanechol and McN-A-343, on the tone of the lower esophageal sphincter led to the ...

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

## Subscription Options

### AccessAnesthesiology Full Site: One-Year Subscription

Connect to the full suite of AccessAnesthesiology content and resources including procedural videos, interactive self-assessment, real-life cases, 20+ textbooks, and more